Lymphoid leukemia, unspecified, in remission is a hematological malignancy characterized by the proliferation of lymphoid cells. This condition is clinically significant as it indicates a previous diagnosis of lymphoid leukemia that has responded to treatment, necessitating accurate coding for effective documentation, billing, and public health reporting. The ICD-10 Code C91.91 ensures precise identification of this condition, facilitating appropriate care and resource allocation.
ICD-10 Code C91.91 represents Lymphoid leukemia, unspecified, in remission, indicating a state where the disease is no longer active following treatment. This code is used when the specific type of lymphoid leukemia is not identified, but the patient is in remission. It is essential for clinical documentation and billing to reflect the patient's current health status accurately.
Lymphoid leukemia, unspecified, in remission occurs when lymphoid cells proliferate abnormally, leading to leukemia, but the disease is currently inactive due to effective treatment. This condition requires ongoing medical supervision to monitor for potential relapse. Early detection and management are crucial for patient outcomes.
ICD-10 Code C91.91 is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's health status and treatment history.
In SOAP notes, ICD-10 Code C91.91 connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of remission. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Lymphoid leukemia, unspecified, in remission focuses on monitoring and supportive care to prevent relapse. Treatment strategies may include:


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C91.91 is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate claims processing.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, typically 15-29 minutes. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count with automated differential. |
| 99214 | Established patient office visit, typically 25-39 minutes. |
Common Questions About Using ICD-10 Code C91.91 for Lymphoid leukemia, unspecified, in remission
What does it mean for lymphoid leukemia to be in remission?
Remission indicates that the signs and symptoms of lymphoid leukemia are no longer present, typically following successful treatment. However, ongoing monitoring is essential as the disease can relapse.
How is ICD-10 Code C91.91 used in billing?
ICD-10 Code C91.91 is used in billing to indicate that a patient has lymphoid leukemia that is currently in remission. Accurate coding is crucial for reimbursement and reflects the patient's health status.
What are the common treatments for lymphoid leukemia?
Common treatments include chemotherapy, targeted therapy, and sometimes stem cell transplantation. Supportive care is also important to manage symptoms and prevent complications.
How often should patients with C91.91 be monitored?
Patients with C91.91 should be monitored regularly, typically every 3-6 months, to assess for any signs of relapse and to manage any long-term effects of treatment.
Clinical Notes
SOAP notes
DAP notes
AI medical notes